5-HT3 receptor

The 5-HT₃ receptor is a member of the superfamily of ligand-gated ion channels, a family that also includes the neuronal nicotinic acetylcholine receptors (nAChRs), and the inhibitory neurotransmitter receptors for GABA (both GABA_A and GABA_C receptors) and glycine.^[1][2] The 5-HT₃ receptor is most closely related by homology to the nicotinic acetylcholine receptor.

The 5-HT₃ receptor consists of 5 subunits arranged around a central ion conducting pore which is permeable to sodium, potassium, and calcium ions. Binding of the neurotransmitter 5-hydroxytryptamine (serotonin) to the 5-HT₃ receptor opens the channel which in turn leads to an excitatory response in neurons. The 5-HT₃ receptor differs markedly in structure and mechanism from the other 5-HT receptor subtypes which are all G-protein-coupled.

Additional recommended knowledge

Daily Visual Balance Check

Safe Weighing Range Ensures Accurate Results

Recognize and detect the effects of electrostatic charges on your balance

Structure

As with other ligand gated ion channels, the 5-HT₃ receptor is composed of five subunits pseudo symmetrically arranged about a central ion conducting pore. These subunits are proteins encoded by the HTR3A, HTR3B, HTR3C, HTR3D, and/or HTR3E genes.

Functional channels may be comprised of five identical 5-HT_3A subunits (homopentameric) or a mixture of 5-HT_3A and one of the other four 5-HT_3B,^[3][4][5] 5-HT_3C, 5-HT_3D, or 5-HT_3E subunits (heteropentameric).^[6] It appears that only the 5-HT_3A subunits form functional homopentameric channels. All other subunit subtypes must heteropentamerize with 5-HT_3A subunits to form functional channels.

Tissue distribution

The 5-HT₃ receptor is expressed throughout the central and peripheral nervous systems and mediates a variety of physiological functions.^[2] On a cellular level, it has been shown that postsynaptic 5-HT₃ receptors mediate fast excitatory synaptic transmission in rat neocortical interneurons and amygdala, and in ferret visual cortex.^[7][8][9] 5-HT₃ receptors are also present on presynaptic nerve terminals, where they are thought to mediate or modulate neurotransmitter release.^[10][11][12]

Effects

When the receptor is activated to open the ion channel by agonists, the following effects are observed:

• CNS: anxiety^[13]
• PNS: neuronal excitation (in autonomic, nociceptive neurons), emesis^[13]

Agonists

Agonists (channel openers) for the receptor include:

• 2-methyl-5-HT
• chlorophenylbiguanide^[13]

Antagonists

Antgonists (channel closers) for the receptor (sorted by their respective therapeutic application) include:

• IBS medications
  • metoclopramide (high doses)
  • renzapride
  • alosetron
• antiemetics
  • ondansetron
  • tropisetron^[13]
  • granisetron^[13]
• mirtazapine (antidepressant)
• memantine (in Alzheimer disease)

Discovery

Identification of the 5-HT₃ receptor did not take place until 1986 because of a lack of selective pharmacological tool.^[2] However, with the discovery that the 5-HT₃ receptor plays a prominent role in chemotherapy- and radiotherapy-induced vomiting, and the concomitant development of selective 5-HT₃ receptor antagonists to suppress these side effects aroused intense interest from the pharmaceutical industry^[14][15] and therefore the identification of 5-HT₃ receptors in cell lines and native tissues quickly followed.^[2]

References